Cerebrospinal Fluid Glutamic Oxalacetic Transaminase Activity in Neurologic Disease
- 1 May 1957
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 7 (5) , 313
- https://doi.org/10.1212/wnl.7.5.313
Abstract
Cerebrospinal fluid transaminase activity was increased in 64% of cerebral infarctions. Levels had prognostic value, being roughly proportional to the magnitude and rapidity of tissue destruction. Cerebrospinal fluid activity reached high levels by the third day, and in some cases continued to increase over several months. In addition to cerebral infarctions, increased activity was found in cerebral hemorrhages, vascular syndromes of the spinal cord, and in some acute cases of multiple sclerosis. Primary brain tumors were not associated with elevations, thus aiding clinical differentiation from infarctions. Increases in serum activity due to liver or muscle disease did not appreciably alter cerebrospinal fluid activity.Keywords
This publication has 3 references indexed in Scilit:
- Serum Glutamic-Oxalacetic Transaminase in Coronary Artery DiseaseCirculation, 1956
- Serum Glutamic Pyruvic Transaminase in Cardiac and Hepatic Disease.Experimental Biology and Medicine, 1956
- FUNCTION OF THE VITAMIN B6 GROUP: MECHANISM OF TRANSAMINATIONJournal of Biological Chemistry, 1948